MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases. Founded by George Frodsham and Quentin Pankhurst in 2015, MediSieve is backed by investors that include MassChallenge, Innovate UK, Wellcome Trust, UK Research and Innovation, and 24 Haymarket and is headquartered in London.